Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | TTR | P02766 | 1/20 | 0.32 |
| ▸ | NSD2 | O96028 | 2/20 | 0.31 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.31 |
| ▸ | CD44 | P16070 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7829524 | 0.83 | SMN1; SMN2 (0.37) | CYP3A4TSHRALDH1A1HPGDHSD17B10 | |
| SCHEMBL8799546 | 0.76 | ALDH1A1 (0.39) | ALDH1A1HPGDHSD17B10KDM4E | |
| SCHEMBL6590934 | 0.74 | CYP3A4 (0.46) | CYP3A4TSHRALDH1A1HPGDHSD17B10 | |
| SCHEMBL7827508 | 0.73 | GPR35 (0.50) | ALDH1A1HPGDKDM4E | |
| SCHEMBL7829502 | 0.72 | ALDH1A1 (0.39) | CYP3A4TSHRALDH1A1HPGDHSD17B10 | |
| SCHEMBL7826135 | 0.71 | ALDH1A1 (0.35) | CYP3A4TSHRALDH1A1HPGDHSD17B10 | |
| SCHEMBL7832336 | 0.70 | GAA (0.55) | CYP3A4ALDH1A1HSD17B10ELANE | |
| SCHEMBL24254913 | 0.69 | ALDH1A1 (0.55) | CYP3A4TSHRALDH1A1HPGDHSD17B10 | |
| SCHEMBL1772150 | 0.69 | CD44 (0.48) | CYP3A4TSHRALDH1A1HPGDHSD17B10 | |
| SCHEMBL23938618 | 0.68 | CYP3A4 (0.35) | CYP3A4TSHRALDH1A1HPGDHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0757682-B1 | BENZOFURAN DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION | FUJISAWA PHARMACEUTICAL CO (JP) | 2001-06-20 | — | — | EP | disclosed |
| US-5858995-A | ADMINISTERING TO HUMANS AND ANIMALS IN THE TREATMENT OF DISEASES CAUSED BY ABNORMAL BONE METABOLISM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-01-12 | — | — | US | disclosed |
| EP-0757682-A1 | BENZOFURAN DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-02-12 | — | — | EP | disclosed |
| WO-1995029907-A1 | BENZOFURAN DERIVATIVES USEFUL AS INHIBITORS OF BONE RESORPTION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1995-11-09 | — | — | WO | disclosed |